Development and validation of virtual reality-based Rey Auditory Verbal Learning Test.

Rey Auditory Verbal Learning test memory and learning tests neuropsychological tests reliability and validity validation study virtual reality

Journal

Frontiers in aging neuroscience
ISSN: 1663-4365
Titre abrégé: Front Aging Neurosci
Pays: Switzerland
ID NLM: 101525824

Informations de publication

Date de publication:
2022
Historique:
received: 28 06 2022
accepted: 09 08 2022
entrez: 3 10 2022
pubmed: 4 10 2022
medline: 4 10 2022
Statut: epublish

Résumé

Translations and adaptations of traditional neuropsychological tests to virtual reality (VR) technology bear the potential to increase their ecological validity since the technology enables simulating everyday life conditions in a controlled manner. The current paper describes our translation of a commonly used neuropsychological test to VR, the Rey Auditory Verbal Learning Test (RAVLT). For this aim, we developed a VR adaptation of the RAVLT (VR-RAVLT) Which is based on a conversation with a secretary in a virtual office using a fully immersive VR system. To validate the VR-RAVLT, we tested its construct validity, its age-related discriminant validity and its test-retest validity in reference to the original gold standard RAVLT (GS-RAVLT). Seventy-eight participants from different age groups performed the GS-RAVLT and the VR-RAVLT tests in a counterbalanced order in addition to other neuropsychological tests. Construct validity was validated using Pearson's correlations coefficients and serial position effects; discriminant validity was validated using receiver operating characteristic area under the curve values and test-retest reliability was validated using intraclass correlation coefficients. Comparing both RAVLTs' format results indicates that the VR-RAVLT has comparable construct, discriminant and test-retest validities. the novel VR-RAVLT and the GS-RAVLT share similar psychometric properties suggesting that the two tests measure the same cognitive construct. This is an indication of the feasibility of adapting the RAVLT to the VR environment. Future developments will employ this approach for clinical diagnosis and treatment.

Identifiants

pubmed: 36185470
doi: 10.3389/fnagi.2022.980093
pmc: PMC9519387
doi:

Types de publication

Journal Article

Langues

eng

Pagination

980093

Informations de copyright

Copyright © 2022 Gottlieb, Doniger, Kimel-Naor, Ben-Gal, Cohen, Iny, Beeri and Plotnik.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Clin Exp Neuropsychol. 2013;35(8):812-26
pubmed: 23961959
Neurology. 1996 Mar;46(3):661-5
pubmed: 8618663
PM R. 2019 Dec;11(12):1278-1286
pubmed: 30900829
Neurol Sci. 2018 Jun;39(6):1029-1034
pubmed: 29550982
Brain Inj. 2004 Nov;18(11):1067-81
pubmed: 15545205
J Clin Exp Neuropsychol. 2013;35(2):113-23
pubmed: 23157431
Arch Clin Neuropsychol. 2002 Apr;17(3):223-33
pubmed: 14589725
Neuropsychol Rehabil. 2009 Apr;19(2):177-207
pubmed: 18720231
Arch Clin Neuropsychol. 2006 Apr;21(3):217-27
pubmed: 16554143
Arch Clin Neuropsychol. 2006 Oct;21(7):693-703
pubmed: 16987634
Cyberpsychol Behav. 2001 Aug;4(4):489-96
pubmed: 11708728
J Int Neuropsychol Soc. 2010 Jan;16(1):205-9
pubmed: 19835661
J Clin Psychol Med Settings. 1994 Sep;1(3):261-8
pubmed: 24227393
Clin Neuropsychol. 2004 Aug;18(3):465-76
pubmed: 15739816
Arch Clin Neuropsychol. 2002 Jan;17(1):69-77
pubmed: 14589754
Arch Iran Med. 2011 Mar;14(2):104-9
pubmed: 21361716
Arch Clin Neuropsychol. 1991;6(1-2):81-8
pubmed: 14589602
Clin Neuropsychol. 1990 Mar;4(1):45-63
pubmed: 29022439
J Clin Psychol. 1993 Nov;49(6):883-90
pubmed: 8300877
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
Arch Clin Neuropsychol. 2013 Feb;28(1):52-64
pubmed: 23179043
Arch Clin Neuropsychol. 1992;7(1):97-107
pubmed: 14589682
Arch Clin Neuropsychol. 1990;5(4):405-10
pubmed: 14589536
Cogn Psychol. 1982 Oct;14(4):590-607
pubmed: 7140212
Neuropsychol Rehabil. 2017 Jul;27(5):777-807
pubmed: 26558491
J Dev Behav Pediatr. 2009 Feb;30(1):2-6
pubmed: 19194324
Clin Neuropsychol. 2010 May;24(4):662-77
pubmed: 20155574
J Neuroeng Rehabil. 2021 May 17;18(1):82
pubmed: 34001179
Br J Psychiatry. 2003 Mar;182:214-20
pubmed: 12611784
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Int J Geriatr Psychiatry. 2003 Nov;18(11):1021-8
pubmed: 14618554
Clin Neuropsychol. 2012;26(6):926-41
pubmed: 22809061

Auteurs

Amihai Gottlieb (A)

Center of Advanced Technologies in Rehabilitation, Sheba Medical Center, Ramat Gan, Israel.

Glen M Doniger (GM)

Center of Advanced Technologies in Rehabilitation, Sheba Medical Center, Ramat Gan, Israel.
Joseph Sagol Neuroscience Center, Sheba Medical Center, Ramat Gan, Israel.

Shani Kimel-Naor (S)

Center of Advanced Technologies in Rehabilitation, Sheba Medical Center, Ramat Gan, Israel.

Oran Ben-Gal (O)

Center of Advanced Technologies in Rehabilitation, Sheba Medical Center, Ramat Gan, Israel.

Maya Cohen (M)

Center of Advanced Technologies in Rehabilitation, Sheba Medical Center, Ramat Gan, Israel.

Hila Iny (H)

Center of Advanced Technologies in Rehabilitation, Sheba Medical Center, Ramat Gan, Israel.

Michal Schnaider Beeri (MS)

Joseph Sagol Neuroscience Center, Sheba Medical Center, Ramat Gan, Israel.
Department of Psychiatry, The Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Meir Plotnik (M)

Center of Advanced Technologies in Rehabilitation, Sheba Medical Center, Ramat Gan, Israel.
Department of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.

Classifications MeSH